US FDA Using Platform Ideas Outside Of Formal Designations To Speed Cell and Gene Approvals

 
• By Sarah Karlin-Smith
FDA's Office of Therapeutic Products Director Nicole Verdun
CBER Office of Therapeutics Director Nicole Verdun spoke on a 14 May Cencora webinar. • Source: Cencora ThinkLive Cell and Gene Therapy Summit

More from Cell & Gene Therapies

More from Advanced Technologies